Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides
Authors:
- Hideo IshitsukaHIHideo Ishitsuka
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 13 (2) , 61-74
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Chemotherapy of rhinovirus coldsAntimicrobial Agents and Chemotherapy, 1988
- A ‘new’ generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactionsAntiviral Research, 1987
- The Site of Attachment in Human Rhinovirus 14 for Antiviral Agents That Inhibit UncoatingScience, 1986
- Synergism between anti-rhinovirus antivirals: Various human interferons and a number of synthetic compoundsAntiviral Research, 1986
- In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drugAntimicrobial Agents and Chemotherapy, 1985
- Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroximeAntimicrobial Agents and Chemotherapy, 1985
- Antivirus agent, Ro 09-0410, binds to rhinovirus specifically and stabilizes the virus conformationVirology, 1984
- Antipicornavirus flavone Ro 09-0179Antimicrobial Agents and Chemotherapy, 1982
- 4′,6-Dichloroflavan (BW683C), a new anti-rhinovirus compoundNature, 1981
- RMI 15,731 (1-[5-tetradecyloxy-2-furanyl]-ethanone), a new antirhinovirus compoundAntimicrobial Agents and Chemotherapy, 1979